We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Warning Wire: Zimmer Biomet Zapped Again

Law360 (February 6, 2018, 9:08 PM EST) -- Zimmer Biomet once again found itself in the crosshairs of the U.S. Food and Drug Administration, which also warned two drugmakers in Asia about quality issues such as fiber particles in drug vials.

Here’s this week’s roundup of FDA enforcement actions.

Zimmer Zinged Again

The FDA issued yet another so-called Form 483 report, made public Tuesday, laying out its findings from an inspection of Zimmer Biomet’s Warsaw, Indiana, plant in October.

At the top of its list of 12 objectionable procedures inspectors observed at the plant...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.